Newsroom
PRESS STATEMENT: ARHP Applauds FDA Approvable Action Letter for Single-Rod Implant
Wayne C. Shields
President and CEO
Association of Reproductive Health Professionals (ARHP)
For Immediate Release
June 22, 2005
Contact: Ann McCall
Phone: (202) 466-3825
E-mail: communications@arhp.org
Web site: www.arhp.org
WASHINGTON, DC ( June 22, 2005)—The Association of Reproductive Health Professionals (ARHP) applauds the FDA’s decision to issue an action letter to continue approvable status for the single-rod implant, an important new contraceptive option for women. Because every woman is unique and has individual needs based on her health, age, lifestyle, and personal preferences, ARHP supports the availability of as many safe, effective contraceptive options as possible. New longer-term contraceptive delivery systems, like the single-rod implant, can be very beneficial to women interested in longer-term protection from unintended pregnancy.
###
The Association of Reproductive Health Professionals (ARHP) is the leading
source for trusted medical education and information on reproductive and sexual
health. ARHP educates health care providers, informs consumers, and helps shape
public policy. ARHP is a non-profit membership association composed of highly
qualified and committed experts in reproductive health. ARHP members are health
professionals in clinical practice, education, research, and advocacy and they
include physicians, nurse practitioners, physician assistants, nurse midwives,
researchers, educators, pharmacists, and other professionals in reproductive
health. To learn more, visit: http://www.arhp.org.
|
